New Users of Angiotensin II Receptor Blocker–Versus Angiotensin‐Converting Enzyme Inhibitor–Based Antihypertensive Medication Regimens and Cardiovascular …
BACKGROUND Angiotensin II receptor blockers (ARBs) and angiotensin‐converting
enzyme inhibitors (ACEIs) block distinct components of the renin‐angiotensin system …
enzyme inhibitors (ACEIs) block distinct components of the renin‐angiotensin system …
Angiotensin receptor blockers and angiotensin‐converting enzyme inhibitors: challenges in comparative effectiveness using Medicare data
S Setoguchi, WH Shrank, J Liu, JC Lee… - Clinical …, 2011 - Wiley Online Library
An evidence gap exists in comparing the effectiveness of angiotensin receptor II blockers
(ARBs) for hypertension with that of angiotensin‐converting enzyme inhibitors (ACEIs). We …
(ARBs) for hypertension with that of angiotensin‐converting enzyme inhibitors (ACEIs). We …
Blood pressure-dependent and independent effects of agents that inhibit the renin–angiotensin system
Blood Pressure Lowering Treatment Trialists' … - Journal of …, 2007 - journals.lww.com
Objectives To evaluate the blood pressure-dependent and independent effects of
angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) …
angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) …
Comparative effectiveness of angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for hypertension on clinical end points: a cohort study
J Clin Hypertens (Greenwich). 2012; 14: 407–414.© 2012 Wiley Periodicals, Inc. Important
questions concerning the comparative effectiveness of angiotensin‐converting enzyme …
questions concerning the comparative effectiveness of angiotensin‐converting enzyme …
Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management
R Petrella, P Michailidis - Clinical therapeutics, 2011 - Elsevier
BACKGROUND: Efficacy of blood pressure (BP) lowering may differ between clinical trials
and what is observed in clinical practice. These differences may contribute to poor BP …
and what is observed in clinical practice. These differences may contribute to poor BP …
Comparative first-line effectiveness and safety of ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers: a multinational cohort study
ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers (ARBs)
are equally guideline-recommended first-line treatments for hypertension, yet few head-to …
are equally guideline-recommended first-line treatments for hypertension, yet few head-to …
Long-term clinical and economic outcomes associated with angiotensin II receptor blocker use in hypertensive patients
JP Swindle, P Buzinec, ŞR Iorga… - … medical research and …, 2011 - Taylor & Francis
Objective: To examine clinical and economic outcomes associated with angiotensin II
receptor blockers (ARB). Methods: Retrospective claims data were analyzed for …
receptor blockers (ARB). Methods: Retrospective claims data were analyzed for …
Comparative cardiovascular effectiveness and safety of individual angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a multinational …
Background Twelve ACE inhibitors (ACEi) and ARBs are commonly used in clinical practice
with limited evidence to guide their relative selection. We evaluated the relative …
with limited evidence to guide their relative selection. We evaluated the relative …
[HTML][HTML] Comparative effectiveness of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor antagonists (ARBs) for treating essential …
In this comparative effectiveness review, we examine the scientific literature on angiotensin-
converting enzyme inhibitors (ACEIs) and angiotensin II receptor antagonists (ARBs, or …
converting enzyme inhibitors (ACEIs) and angiotensin II receptor antagonists (ARBs, or …
Effectiveness of angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers on total and cardiovascular mortality and morbidity in primary prevention …
E Oger, S Kerbrat, E Nowak, F Paillard… - The Journal of …, 2022 - Wiley Online Library
Angiotensin‐converting enzyme (ACE) inhibitors and angiotensin II receptor blockers
(ARBs) both inhibit the renin‐angiotensin system (RAS) but have different sites of action …
(ARBs) both inhibit the renin‐angiotensin system (RAS) but have different sites of action …